Related Experiment Videos
Extra-uterine endometrial stromal sarcoma with DNA flow cytometric analysis
M E Vierhout1, S Chadha-Ajwani, J A Wijnen
1Department of Obstetrics & Gynecology, Ikazia Hospital, Rotterdam, The Netherlands.
European Journal of Obstetrics, Gynecology, and Reproductive Biology
|January 31, 1992
Summary
This study describes an extra-uterine low-grade endometrial stromal sarcoma, detailing its clinical course and treatment. Microscopy and DNA flow cytometry illustrate the transition from endometriosis to malignancy, highlighting DNA content changes as a potential diagnostic aid.
Area of Science:
- Gynecologic Oncology
- Surgical Pathology
- Cancer Biology
Background:
- Endometrial stromal sarcoma (ESS) is a rare uterine malignancy.
- Extra-uterine ESS, originating outside the uterus, presents diagnostic challenges.
- Low-grade ESS can exhibit benign-like microscopic features, complicating early detection.
Observation:
- A case of primarily extra-uterine low-grade endometrial stromal sarcoma is presented.
- The patient's clinical journey involved multiple treatment modalities including surgery, chemotherapy, and hormonal therapy.
- Microscopic examination and DNA flow cytometry were employed to analyze tumor characteristics.
Findings:
- The study illustrates the pathological transition from benign endometriosis to malignant endometrial stromal sarcoma.
- A demonstrable change in nuclear DNA content was observed.
- This alteration in DNA content may serve as a valuable indicator of malignant potential.
Implications:
- Understanding the transition from endometriosis to ESS is crucial for accurate diagnosis.
- DNA flow cytometry offers a potential method for identifying the malignant potential of ambiguous tumors.
- This case contributes to the understanding of rare extra-uterine gynecologic malignancies and their management.